2024 –The Food and Drug Administration’s (FDA) final rule has reclassified laboratory developed tests (LDTs) as medical devices, according to Avalere. The rule leads to a paradigm shift that ...
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...
Affinity Technologies today announced strategic actions to cut $4 million in annual costs at its subsidiary CAP/CLIA ...
The test measures a protein biomarker and can be used to diagnose and manage patients with the progressive autoimmune disorder.
A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The words drug, medication and medicine are often used interchangeably.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, ...
After hours: March 7 at 5:27:31 p.m. EST Loading Chart for GH ...
On Feb. 19, the organization announced that it would roll out Ambience Healthcare’s AI platform for documentation, clinical documentation integrity and point-of-care coding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback